Vaginal laser together with the use of moisturizing and repairing gels could be an effective therapy for the treatment of genitourinary syndrome in women with a history of neoplasia in whom the use of estrogens is not recommended.
The purpose of this study is to evaluate the effectiveness of vaginal laser together with adjuvant treatment with a hydrating and repairing niosomal gel as a beneficial treatment in this group of patients.
Patients with an established SGM diagnosis.
Patients with a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended.
Patients with concomitant vulvovaginal pathology.
Patients with a diagnosis of pelvic organ prolapse grade II or greater.
Patients with an established SGM diagnosis who have a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended.
Cohort
Prospective
CO2 laser
DeviceApplication of CO2 vulvo-vaginal laser according to standard therapy and moisturizing gels
Effectiveness
To evaluate the effectiveness of CO2 vaginal laser together with adjuvant treatment with a hydrating and repairing niosomal gel as a beneficial treatment in patients with a history of neoplasia in whom the use of estrogens is not recommended
Security
To determine the safety (side effects) of vaginal laser therapy
Duration
To determine the durability of the effects produced by vaginal laser therapy
Click on the lead sponsor to view all of their trials.
